Organic Infant Formula Milk Powder
Organic Infant Formula Milk Powder market is segmented by Type and by Application. Players, stake ... Read More
Global Opioids Drug Market Insights and Forecast to 2028
1 Study Coverage
1.1 Opioids Drug Product Introduction
1.2 Market by Type
1.2.1 Global Opioids Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.3 Market by Application
1.3.1 Global Opioids Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Opioids Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Opioids Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Opioids Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Opioids Drug Sales by Region
2.4.1 Global Opioids Drug Sales by Region (2017-2022)
2.4.2 Global Sales Opioids Drug by Region (2023-2028)
2.5 Global Opioids Drug Revenue by Region
2.5.1 Global Opioids Drug Revenue by Region (2017-2022)
2.5.2 Global Opioids Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Opioids Drug Sales by Manufacturers
3.1.1 Global Top Opioids Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Opioids Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Opioids Drug in 2021
3.2 Global Opioids Drug Revenue by Manufacturers
3.2.1 Global Opioids Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Opioids Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Opioids Drug Revenue in 2021
3.3 Global Opioids Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Opioids Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Opioids Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Opioids Drug Sales by Type
4.1.1 Global Opioids Drug Historical Sales by Type (2017-2022)
4.1.2 Global Opioids Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Opioids Drug Sales Market Share by Type (2017-2028)
4.2 Global Opioids Drug Revenue by Type
4.2.1 Global Opioids Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Opioids Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Opioids Drug Revenue Market Share by Type (2017-2028)
4.3 Global Opioids Drug Price by Type
4.3.1 Global Opioids Drug Price by Type (2017-2022)
4.3.2 Global Opioids Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Opioids Drug Sales by Application
5.1.1 Global Opioids Drug Historical Sales by Application (2017-2022)
5.1.2 Global Opioids Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Opioids Drug Sales Market Share by Application (2017-2028)
5.2 Global Opioids Drug Revenue by Application
5.2.1 Global Opioids Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Opioids Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Opioids Drug Revenue Market Share by Application (2017-2028)
5.3 Global Opioids Drug Price by Application
5.3.1 Global Opioids Drug Price by Application (2017-2022)
5.3.2 Global Opioids Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Opioids Drug Market Size by Type
6.1.1 North America Opioids Drug Sales by Type (2017-2028)
6.1.2 North America Opioids Drug Revenue by Type (2017-2028)
6.2 North America Opioids Drug Market Size by Application
6.2.1 North America Opioids Drug Sales by Application (2017-2028)
6.2.2 North America Opioids Drug Revenue by Application (2017-2028)
6.3 North America Opioids Drug Market Size by Country
6.3.1 North America Opioids Drug Sales by Country (2017-2028)
6.3.2 North America Opioids Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Opioids Drug Market Size by Type
7.1.1 Europe Opioids Drug Sales by Type (2017-2028)
7.1.2 Europe Opioids Drug Revenue by Type (2017-2028)
7.2 Europe Opioids Drug Market Size by Application
7.2.1 Europe Opioids Drug Sales by Application (2017-2028)
7.2.2 Europe Opioids Drug Revenue by Application (2017-2028)
7.3 Europe Opioids Drug Market Size by Country
7.3.1 Europe Opioids Drug Sales by Country (2017-2028)
7.3.2 Europe Opioids Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Opioids Drug Market Size by Type
8.1.1 Asia Pacific Opioids Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Opioids Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Opioids Drug Market Size by Application
8.2.1 Asia Pacific Opioids Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Opioids Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Opioids Drug Market Size by Region
8.3.1 Asia Pacific Opioids Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Opioids Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Opioids Drug Market Size by Type
9.1.1 Latin America Opioids Drug Sales by Type (2017-2028)
9.1.2 Latin America Opioids Drug Revenue by Type (2017-2028)
9.2 Latin America Opioids Drug Market Size by Application
9.2.1 Latin America Opioids Drug Sales by Application (2017-2028)
9.2.2 Latin America Opioids Drug Revenue by Application (2017-2028)
9.3 Latin America Opioids Drug Market Size by Country
9.3.1 Latin America Opioids Drug Sales by Country (2017-2028)
9.3.2 Latin America Opioids Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Opioids Drug Market Size by Type
10.1.1 Middle East and Africa Opioids Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Opioids Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Opioids Drug Market Size by Application
10.2.1 Middle East and Africa Opioids Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Opioids Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Opioids Drug Market Size by Country
10.3.1 Middle East and Africa Opioids Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Opioids Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Overview
11.1.3 Teva Opioids Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Teva Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Recent Developments
11.2 Purdue Pharma
11.2.1 Purdue Pharma Corporation Information
11.2.2 Purdue Pharma Overview
11.2.3 Purdue Pharma Opioids Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Purdue Pharma Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Purdue Pharma Recent Developments
11.3 Mallinckrodt
11.3.1 Mallinckrodt Corporation Information
11.3.2 Mallinckrodt Overview
11.3.3 Mallinckrodt Opioids Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Mallinckrodt Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mallinckrodt Recent Developments
11.4 Amneal Pharma
11.4.1 Amneal Pharma Corporation Information
11.4.2 Amneal Pharma Overview
11.4.3 Amneal Pharma Opioids Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Amneal Pharma Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amneal Pharma Recent Developments
11.5 Collegium
11.5.1 Collegium Corporation Information
11.5.2 Collegium Overview
11.5.3 Collegium Opioids Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Collegium Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Collegium Recent Developments
11.6 J&J
11.6.1 J&J Corporation Information
11.6.2 J&J Overview
11.6.3 J&J Opioids Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 J&J Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 J&J Recent Developments
11.7 Endo
11.7.1 Endo Corporation Information
11.7.2 Endo Overview
11.7.3 Endo Opioids Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Endo Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Endo Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Opioids Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 INSYS
11.9.1 INSYS Corporation Information
11.9.2 INSYS Overview
11.9.3 INSYS Opioids Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 INSYS Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 INSYS Recent Developments
11.10 Mylan
11.10.1 Mylan Corporation Information
11.10.2 Mylan Overview
11.10.3 Mylan Opioids Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Mylan Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mylan Recent Developments
11.11 Hikma
11.11.1 Hikma Corporation Information
11.11.2 Hikma Overview
11.11.3 Hikma Opioids Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Hikma Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hikma Recent Developments
11.12 Egalet
11.12.1 Egalet Corporation Information
11.12.2 Egalet Overview
11.12.3 Egalet Opioids Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Egalet Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Egalet Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Opioids Drug Industry Chain Analysis
12.2 Opioids Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Opioids Drug Production Mode & Process
12.4 Opioids Drug Sales and Marketing
12.4.1 Opioids Drug Sales Channels
12.4.2 Opioids Drug Distributors
12.5 Opioids Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Opioids Drug Industry Trends
13.2 Opioids Drug Market Drivers
13.3 Opioids Drug Market Challenges
13.4 Opioids Drug Market Restraints
14 Key Findings in The Global Opioids Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Opioids Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oxycodone
Table 3. Major Manufacturers of Hydromorphone
Table 4. Major Manufacturers of Codeine
Table 5. Major Manufacturers of Fentanyl
Table 6. Global Opioids Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Opioids Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Opioids Drug Sales by Region (2017-2022) & (M Units)
Table 9. Global Opioids Drug Sales Market Share by Region (2017-2022)
Table 10. Global Opioids Drug Sales by Region (2023-2028) & (M Units)
Table 11. Global Opioids Drug Sales Market Share by Region (2023-2028)
Table 12. Global Opioids Drug Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Opioids Drug Revenue Market Share by Region (2017-2022)
Table 14. Global Opioids Drug Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Opioids Drug Revenue Market Share by Region (2023-2028)
Table 16. Global Opioids Drug Sales by Manufacturers (2017-2022) & (M Units)
Table 17. Global Opioids Drug Sales Share by Manufacturers (2017-2022)
Table 18. Global Opioids Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Opioids Drug Revenue Share by Manufacturers (2017-2022)
Table 20. Opioids Drug Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global Opioids Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Opioids Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Drug as of 2021)
Table 23. Opioids Drug Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Opioids Drug Product Offered
Table 25. Date of Manufacturers Enter into Opioids Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 28. Global Opioids Drug Sales by Type (2023-2028) & (M Units)
Table 29. Global Opioids Drug Sales Share by Type (2017-2022)
Table 30. Global Opioids Drug Sales Share by Type (2023-2028)
Table 31. Global Opioids Drug Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Opioids Drug Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Opioids Drug Revenue Share by Type (2017-2022)
Table 34. Global Opioids Drug Revenue Share by Type (2023-2028)
Table 35. Opioids Drug Price by Type (2017-2022) & (USD/Unit)
Table 36. Global Opioids Drug Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 38. Global Opioids Drug Sales by Application (2023-2028) & (M Units)
Table 39. Global Opioids Drug Sales Share by Application (2017-2022)
Table 40. Global Opioids Drug Sales Share by Application (2023-2028)
Table 41. Global Opioids Drug Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Opioids Drug Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Opioids Drug Revenue Share by Application (2017-2022)
Table 44. Global Opioids Drug Revenue Share by Application (2023-2028)
Table 45. Opioids Drug Price by Application (2017-2022) & (USD/Unit)
Table 46. Global Opioids Drug Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 48. North America Opioids Drug Sales by Type (2023-2028) & (M Units)
Table 49. North America Opioids Drug Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Opioids Drug Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 52. North America Opioids Drug Sales by Application (2023-2028) & (M Units)
Table 53. North America Opioids Drug Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Opioids Drug Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Opioids Drug Sales by Country (2017-2022) & (M Units)
Table 56. North America Opioids Drug Sales by Country (2023-2028) & (M Units)
Table 57. North America Opioids Drug Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Opioids Drug Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 60. Europe Opioids Drug Sales by Type (2023-2028) & (M Units)
Table 61. Europe Opioids Drug Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Opioids Drug Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 64. Europe Opioids Drug Sales by Application (2023-2028) & (M Units)
Table 65. Europe Opioids Drug Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Opioids Drug Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Opioids Drug Sales by Country (2017-2022) & (M Units)
Table 68. Europe Opioids Drug Sales by Country (2023-2028) & (M Units)
Table 69. Europe Opioids Drug Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Opioids Drug Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 72. Asia Pacific Opioids Drug Sales by Type (2023-2028) & (M Units)
Table 73. Asia Pacific Opioids Drug Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Opioids Drug Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 76. Asia Pacific Opioids Drug Sales by Application (2023-2028) & (M Units)
Table 77. Asia Pacific Opioids Drug Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Opioids Drug Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Opioids Drug Sales by Region (2017-2022) & (M Units)
Table 80. Asia Pacific Opioids Drug Sales by Region (2023-2028) & (M Units)
Table 81. Asia Pacific Opioids Drug Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Opioids Drug Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 84. Latin America Opioids Drug Sales by Type (2023-2028) & (M Units)
Table 85. Latin America Opioids Drug Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Opioids Drug Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 88. Latin America Opioids Drug Sales by Application (2023-2028) & (M Units)
Table 89. Latin America Opioids Drug Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Opioids Drug Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Opioids Drug Sales by Country (2017-2022) & (M Units)
Table 92. Latin America Opioids Drug Sales by Country (2023-2028) & (M Units)
Table 93. Latin America Opioids Drug Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Opioids Drug Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 96. Middle East and Africa Opioids Drug Sales by Type (2023-2028) & (M Units)
Table 97. Middle East and Africa Opioids Drug Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Opioids Drug Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 100. Middle East and Africa Opioids Drug Sales by Application (2023-2028) & (M Units)
Table 101. Middle East and Africa Opioids Drug Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Opioids Drug Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Opioids Drug Sales by Country (2017-2022) & (M Units)
Table 104. Middle East and Africa Opioids Drug Sales by Country (2023-2028) & (M Units)
Table 105. Middle East and Africa Opioids Drug Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Opioids Drug Revenue by Country (2023-2028) & (US$ Million)
Table 107. Teva Corporation Information
Table 108. Teva Description and Major Businesses
Table 109. Teva Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Teva Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Teva Recent Developments
Table 112. Purdue Pharma Corporation Information
Table 113. Purdue Pharma Description and Major Businesses
Table 114. Purdue Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Purdue Pharma Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Purdue Pharma Recent Developments
Table 117. Mallinckrodt Corporation Information
Table 118. Mallinckrodt Description and Major Businesses
Table 119. Mallinckrodt Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Mallinckrodt Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Mallinckrodt Recent Developments
Table 122. Amneal Pharma Corporation Information
Table 123. Amneal Pharma Description and Major Businesses
Table 124. Amneal Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Amneal Pharma Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Amneal Pharma Recent Developments
Table 127. Collegium Corporation Information
Table 128. Collegium Description and Major Businesses
Table 129. Collegium Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Collegium Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Collegium Recent Developments
Table 132. J&J Corporation Information
Table 133. J&J Description and Major Businesses
Table 134. J&J Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. J&J Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. J&J Recent Developments
Table 137. Endo Corporation Information
Table 138. Endo Description and Major Businesses
Table 139. Endo Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. Endo Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Endo Recent Developments
Table 142. Pfizer Corporation Information
Table 143. Pfizer Description and Major Businesses
Table 144. Pfizer Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. Pfizer Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Pfizer Recent Developments
Table 147. INSYS Corporation Information
Table 148. INSYS Description and Major Businesses
Table 149. INSYS Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 150. INSYS Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. INSYS Recent Developments
Table 152. Mylan Corporation Information
Table 153. Mylan Description and Major Businesses
Table 154. Mylan Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 155. Mylan Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Mylan Recent Developments
Table 157. Hikma Corporation Information
Table 158. Hikma Description and Major Businesses
Table 159. Hikma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 160. Hikma Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Hikma Recent Developments
Table 162. Egalet Corporation Information
Table 163. Egalet Description and Major Businesses
Table 164. Egalet Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 165. Egalet Opioids Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Egalet Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Opioids Drug Distributors List
Table 170. Opioids Drug Customers List
Table 171. Opioids Drug Market Trends
Table 172. Opioids Drug Market Drivers
Table 173. Opioids Drug Market Challenges
Table 174. Opioids Drug Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioids Drug Product Picture
Figure 3. Global Opioids Drug Market Share by Type in 2021 & 2028
Figure 3. Oxycodone Product Picture
Figure 4. Hydromorphone Product Picture
Figure 5. Codeine Product Picture
Figure 6. Fentanyl Product Picture
Figure 7. Global Opioids Drug Market Share by Application in 2021 & 2028
Figure 8. Pain Relief
Figure 9. Anesthesia
Figure 10. Others
Figure 11. Opioids Drug Report Years Considered
Figure 12. Global Opioids Drug Sales 2017-2028 (M Units)
Figure 13. Global Opioids Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Opioids Drug Revenue 2017-2028 (US$ Million)
Figure 15. Global Opioids Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Opioids Drug Sales Market Share by Region (2017-2022)
Figure 17. Global Opioids Drug Sales Market Share by Region (2023-2028)
Figure 18. North America Opioids Drug Sales YoY (2017-2028) & (M Units)
Figure 19. North America Opioids Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Opioids Drug Sales YoY (2017-2028) & (M Units)
Figure 21. Europe Opioids Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Opioids Drug Sales YoY (2017-2028) & (M Units)
Figure 23. Asia-Pacific Opioids Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Opioids Drug Sales YoY (2017-2028) & (M Units)
Figure 25. Latin America Opioids Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Opioids Drug Sales YoY (2017-2028) & (M Units)
Figure 27. Middle East & Africa Opioids Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Opioids Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Opioids Drug in the World: Market Share by Opioids Drug Revenue in 2021
Figure 30. Global Opioids Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Opioids Drug Sales Market Share by Type (2017-2028)
Figure 32. Global Opioids Drug Revenue Market Share by Type (2017-2028)
Figure 33. Global Opioids Drug Sales Market Share by Application (2017-2028)
Figure 34. Global Opioids Drug Revenue Market Share by Application (2017-2028)
Figure 35. North America Opioids Drug Sales Market Share by Type (2017-2028)
Figure 36. North America Opioids Drug Revenue Market Share by Type (2017-2028)
Figure 37. North America Opioids Drug Sales Market Share by Application (2017-2028)
Figure 38. North America Opioids Drug Revenue Market Share by Application (2017-2028)
Figure 39. North America Opioids Drug Sales Share by Country (2017-2028)
Figure 40. North America Opioids Drug Revenue Share by Country (2017-2028)
Figure 41. U.S. Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Opioids Drug Sales Market Share by Type (2017-2028)
Figure 44. Europe Opioids Drug Revenue Market Share by Type (2017-2028)
Figure 45. Europe Opioids Drug Sales Market Share by Application (2017-2028)
Figure 46. Europe Opioids Drug Revenue Market Share by Application (2017-2028)
Figure 47. Europe Opioids Drug Sales Share by Country (2017-2028)
Figure 48. Europe Opioids Drug Revenue Share by Country (2017-2028)
Figure 49. Germany Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 50. France Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Opioids Drug Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Opioids Drug Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Opioids Drug Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Opioids Drug Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Opioids Drug Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Opioids Drug Revenue Share by Region (2017-2028)
Figure 60. China Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 63. India Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Opioids Drug Sales Market Share by Type (2017-2028)
Figure 70. Latin America Opioids Drug Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Opioids Drug Sales Market Share by Application (2017-2028)
Figure 72. Latin America Opioids Drug Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Opioids Drug Sales Share by Country (2017-2028)
Figure 74. Latin America Opioids Drug Revenue Share by Country (2017-2028)
Figure 75. Mexico Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Opioids Drug Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Opioids Drug Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Opioids Drug Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Opioids Drug Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Opioids Drug Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Opioids Drug Revenue Share by Country (2017-2028)
Figure 84. Turkey Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Opioids Drug Revenue (2017-2028) & (US$ Million)
Figure 87. Opioids Drug Value Chain
Figure 88. Opioids Drug Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Teva Purdue Pharma Mallinckrodt Amneal Pharma Collegium J&J Endo Pfizer INSYS Mylan Hikma Egalet